BlackRock Inc. - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 109 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$160,481,000
+6.3%
1,418,925
-5.9%
0.01%
+12.5%
Q1 2017$151,007,000
+639.5%
1,508,096
+694.1%
0.01%
-72.4%
Q4 2016$20,420,000
+47.1%
189,913
+70.3%
0.03%
+45.0%
Q3 2016$13,884,000
+22.6%
111,538
+4.7%
0.02%
+17.6%
Q2 2016$11,328,000
-18.9%
106,539
-12.6%
0.02%
-22.7%
Q1 2016$13,962,000
-17.8%
121,955
+2.3%
0.02%
-12.0%
Q4 2015$16,987,000
+79.2%
119,238
+13.0%
0.02%
+66.7%
Q3 2015$9,478,000
-48.6%
105,511
-34.1%
0.02%
-44.4%
Q2 2015$18,431,000160,0440.03%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q2 2015
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 8,344,200$960,918,0007.67%
RUDMAN ERROL M 130,201$14,994,0005.06%
Ativo Capital Management LLC 59,101$7,258,0002.56%
Kylin Management 188,226$21,676,0002.36%
Monashee Investment Management LLC 40,000$4,606,0002.17%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 62,866$7,240,0001.91%
Cormorant Asset Management, LP 111,500$12,840,0001.71%
OBERWEIS ASSET MANAGEMENT INC/ 53,500$6,161,0001.63%
Perceptive Advisors 147,604$16,998,0001.02%
Granite Point Capital Management, L.P. 29,160$3,358,0000.98%
View complete list of CHINA BIOLOGIC PRODS INC shareholders